Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) Gross Profit (2016 - 2025)

InspireMD (NSPR) has 16 years of Gross Profit data on record, last reported at $864000.0 in Q3 2025.

  • For Q3 2025, Gross Profit rose 108.7% year-over-year to $864000.0; the TTM value through Sep 2025 reached $1.9 million, up 25.68%, while the annual FY2024 figure was $1.5 million, 16.66% down from the prior year.
  • Gross Profit reached $864000.0 in Q3 2025 per NSPR's latest filing, up from $313000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $864000.0 in Q3 2025 and bottomed at $92000.0 in Q3 2021.
  • Average Gross Profit over 5 years is $350157.9, with a median of $331000.0 recorded in 2024.
  • The widest YoY moves for Gross Profit: up 318.33% in 2021, down 69.13% in 2021.
  • A 5-year view of Gross Profit shows it stood at $294000.0 in 2021, then tumbled by 32.65% to $198000.0 in 2022, then surged by 155.05% to $505000.0 in 2023, then decreased by 7.13% to $469000.0 in 2024, then skyrocketed by 84.22% to $864000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $864000.0 in Q3 2025, $313000.0 in Q2 2025, and $292000.0 in Q1 2025.